We are live on ! Find out more
AC

Ascend Capital Portfolio holdings

AUM $1.99B
1-Year Est. Return 10.36%
This Fund
S&P 500
This Quarter Est. Return
+4.12%
1 Year Est. Return
+10.36%
3 Year Est. Return
+56.79%
5 Year Est. Return
+86.43%
10 Year Est. Return
AUM
$3B
AUM Growth
-$844M
Cap. Flow
-$1.01B
Cap. Flow %
-33.73%
Top 10 Hldgs %
26.42%
Holding
246
New
68
Increased
28
Reduced
60
Closed
83

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$76.1M
2
PFE icon
Pfizer
PFE
+$68.2M
3
HON icon
Honeywell
HON
+$47.8M
4
FWONA icon
Liberty Media Series A
FWONA
+$43.6M
5
MEOH icon
Methanex
MEOH
+$41.5M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$154M
2
SIG icon
Signet Jewelers
SIG
+$71.5M
3
IP icon
International Paper
IP
+$64M
4
DIS icon
Walt Disney
DIS
+$62.5M
5
MHK icon
Mohawk Industries
MHK
+$58M

Sector Composition

Rank Sector Weight
1 Financials 13.62%
2 Technology 12.79%
3 Communication Services 12.02%
4 Industrials 11.66%
5 Healthcare 10.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATVI
51
DELISTED
Activision Blizzard
ATVI
$18.1M 0.6%
811,146
-538,854
-40% -$11.1M
AXP icon
52
American Express
AXP
$233B
$18M 0.6%
189,268
-36,307
-16% -$3.27M
PSX icon
53
Phillips 66
PSX
$83B
$17M 0.57%
+211,163
New +$17.4M
AON icon
54
Aon
AON
$76B
$16.9M 0.56%
187,322
-30,728
-14% -$2.66M
BECN
55
DELISTED
Beacon Roofing Supply, Inc.
BECN
$16.6M 0.55%
+500,000
New +$17.6M
TDC icon
56
Teradata
TDC
$2.6B
$16.3M 0.54%
405,372
-382,628
-49% -$16.7M
AGN
57
DELISTED
Allergan Inc
AGN
$16.1M 0.54%
+95,414
New +$14.9M
ODP
58
DELISTED
ODP
ODP
$15.6M 0.52%
+275,000
New +$13.4M
GRMN
59
Garmin
GRMN
$46.3B
$15.3M 0.51%
+250,479
New +$14.4M
BLK icon
60
Blackrock
BLK
$161B
$15.1M 0.5%
47,382
+1,357
+3% +$416K
PRU icon
61
Prudential Financial
PRU
$40.9B
$15M 0.5%
169,308
-15,142
-8% -$1.27M
TFCFA
62
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$14.9M 0.5%
425,000
-1,255,000
-75% -$42.7M
RITM icon
63
Rithm Capital
RITM
$5.01B
$14.9M 0.5%
+1,182,233
New +$15M
CPAY icon
64
Corpay
CPAY
$23.8B
$14.9M 0.5%
113,017
-383
-0.3% -$46.8K
PFE icon
65
CALL
Pfizer
PFE
$143B
$14.8M 0.49%
+527,000
New +$15M
TROX icon
66
Tronox
TROX
$1.02B
$14.8M 0.49%
+549,362
New +$14.1M
PARA
67
DELISTED
Paramount Global Class B
PARA
$14.6M 0.49%
+235,000
New +$14M
BFH icon
68
Bread Financial
BFH
$4.19B
$14.2M 0.47%
63,404
-5,010
-7% -$1.02M
PACW
69
DELISTED
PacWest Bancorp
PACW
$14.2M 0.47%
328,312
+54,117
+20% +$2.26M
MTG icon
70
MGIC Investment
MTG
$6.12B
$14M 0.47%
1,515,500
-279,210
-16% -$2.42M
MW
71
DELISTED
THE MENS WAREHOUSE INC
MW
$13.9M 0.46%
+250,000
New +$12.7M
GLNG icon
72
Golar LNG
GLNG
$5.07B
$13.5M 0.45%
+224,316
New +$10.5M
PEP icon
73
PepsiCo
PEP
$184B
$13.4M 0.45%
+150,000
New +$13M
MSI icon
74
Motorola Solutions
MSI
$67.6B
$13.3M 0.44%
+200,000
New +$13.2M
FL
75
DELISTED
Foot Locker
FL
$13.3M 0.44%
261,422
-563,807
-68% -$27M

Similar funds

Ascend Capital's Q2 2014 Portfolio in Review

As of Q2 2014, Ascend Capital held 246 positions worth $3B, down 22% from $3.85B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Ascend Capital withdrew a net $1.01B in Q2 2014, closing 83 positions and reducing 60 holdings. Its most notable exit was Verizon, an estimated $154M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Ascend Capital opened a new position in Pfizer worth $67.4M.

  • Ascend Capital's largest Q2 2014 buy was Pfizer: 2,391,995 shares worth $67.4M.
  • Ascend Capital added most to RTX Corp in Q2 2014, an estimated $76.1M increase.
  • Ascend Capital's biggest Q2 2014 reduction was International Paper, cutting an estimated $64M.
  • Ascend Capital fully exited Verizon in Q2 2014, selling an estimated $154M.
  • Ascend Capital's ten largest holdings make up 26% of its $3B portfolio in Q2 2014.
  • Ascend Capital opened 68 new positions and closed 83 in Q2 2014.
  • Ascend Capital's portfolio value fell 22% quarter-over-quarter to $3B.

Based on Ascend Capital's 13F filing for Q2 2014, filed 13 Aug 2014.